P-049. Thyroid axis in GH deficient children during GH therapy

A. Rossodivita, C. Latella, A. Necci, G. F. Butera, F. Colabucci

Research output: Contribution to journalArticle

Abstract

The preliminary results of an ongoing study of the effect of rhGH (0,8 IU/kg/w) on pituitary-thyroid axis in 45 GHD children are reported (C.A:11,5 ± 2,9 yr). Nineteen age-matched normal children served as controls. Other hormone deficiencies were excluded. T3, T4, FT3, FT4, T3/T4 ratio and TSH were assessed at 0-3-6-12 months' GH therapy. Data on TSH-curve after TRH(AUC) were available at baseline in all subjects and after 6-12 months of rhGH in 10 and 15 GHD children respectively. Neither differences in basal hormone levels between controls and GHD nor changes during rhGH were observed. However in GHD children the significantly lower pretreatment TSH-AUC values (501 ± 187 μ UI/ml/90'), compared to normal (691 ± 192), strikingly increased after 6 (893 ± 377) and 12 months' therapy (670 ± 200). rhGH did not affect the thyroid function in all but 2 GHD children, who developed hypothyroidism after 6 months. In spite of normal thyroid hormone levels, their TSH-AUC values were more than twice the average of controls as well as of euthyroid GH-treated children, while TSH basal level was normal in one of them and only slightly increased in the other. Our data point out the relevance of TSH-AUC after TRH in detecting mild thyroid axis changes in GHD as well as in its use as a sensitive index of the development of hypothyroidism induced by rhGH.

Original languageEnglish
Pages (from-to)54
Number of pages1
JournalEndocrinology and Metabolism, Supplement
Volume4
Issue numberA
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'P-049. Thyroid axis in GH deficient children during GH therapy'. Together they form a unique fingerprint.

  • Cite this

    Rossodivita, A., Latella, C., Necci, A., Butera, G. F., & Colabucci, F. (1997). P-049. Thyroid axis in GH deficient children during GH therapy. Endocrinology and Metabolism, Supplement, 4(A), 54.